Comparison Chart Purple Biotech Ltd

Equities

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:06 2024-05-21 am EDT			5-day change	1st Jan Change
19.5 ^ILa	+4.28%		+0.52%	-38.87%

Apr. 25	Purple Biotech Ltd.'s Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting	CI
Mar. 14	Purple Biotech Reports Preclinical Proof of Concept for Its Tribody Platform Technology	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	PURPLE BIOTECH LTD	Bio Therapeutic Drugs	+4.28%	+0.52%	-38.87%	-70.94%	-94.46%	13.26M	-	-	-